Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132062) titled 'National Multicenter Real-World Registry of rhTNK-tPA Intravenous Thrombolysis for Acute Ischemic Stroke' on Sept. 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: The First People's Hospital of Foshan

Condition: Acute ischemic stroke

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-21

Target Sample Size: Observation group:8000;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=341577

Published by HT Digital Content Services with permission from Health Daily Digest....